The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer's Disease in a Korean Population.
OBJECTIVE
To examine the validity and reliability of the MMSE-2 for assessing patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) in a Korean population. Specifically, the usefulness of the MMSE-2 as a screening measure for detecting early cognitive change, which has not been detectable through the MMSE, was examined.


METHODS
Two-hundred and twenty-six patients with MCI, 97 patients with AD, and 91 healthy older adults were recruited. All participants consented to examination with the MMSE-2, the MMSE, and other detailed neuropsychological assessments.


RESULTS
The MMSE-2 performed well in discriminating participants across Clinical Dementia Rating (CDR) stages and CDR-Sum of Boxes (CDR-SOB), and it showed excellent internal consistency, high test-retest reliability, high interrater reliability, and good concurrent validity with the MMSE and other detailed neuropsychological assessments. The MMSE-2 was divided into two factors (tests that are sensitive to decline in cognitive functions vs. tests that are not sensitive to decline in cognitive functions) in normal cognitive aging. Moreover, the MMSE-2 was divided into two factors (tests related overall cognitive functioning other than memory vs. tests related to episodic memory) in patients with AD. Finally, the MMSE-2 was divided into three factors (tests related to working memory and frontal lobe functioning vs. tests related to verbal memory vs. tests related to orientation and immediate recall) in patients with MCI. The sensitivity and specificity of the three versions of the MMSE-2 were relatively high in discriminating participants with normal cognitive aging from patients with MCI and AD.


CONCLUSIONS
The MMSE-2 is a valid and reliable cognitive screening instrument for assessing cognitive impairment in a Korean population, but its ability to distinguish patients with MCI from those with normal cognitive aging may not be as highly sensitive as expected.
Clinical Neuroscience Institute, Seoul National University Bundang Hospital, Seoungnam-si, Gyeonggi-do, Republic of Korea.|Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Min Jae
MJ
Baek
Clinical Neuroscience Institute, Seoul National University Bundang Hospital, Seoungnam-si, Gyeonggi-do, Republic of Korea.
Karyeong
K
Kim
Clinical Neuroscience Institute, Seoul National University Bundang Hospital, Seoungnam-si, Gyeonggi-do, Republic of Korea.|Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Young Ho
YH
Park
Clinical Neuroscience Institute, Seoul National University Bundang Hospital, Seoungnam-si, Gyeonggi-do, Republic of Korea.|Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea.
SangYun
S
Kim
Arch Neurol. 2010 Jun;67(6):746-9
20558394
Neurology. 1993 Nov;43(11):2412-4
8232972
Arch Clin Neuropsychol. 2005 Jul;20(5):623-9
15939186
Arch Neurol. 2001 Dec;58(12):1985-92
11735772
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
J Psychiatr Res. 1989;23(1):87-96
2666647
Arch Clin Neuropsychol. 1994 Jul;9(4):337-46
14589626
Compr Gerontol A. 1988 Jun;2(2):87-93
3228822
Psychol Aging. 1988 Mar;3(1):3-16
3077318
Arch Neurol. 1994 Sep;51(9):888-95
8080388
J Nerv Ment Dis. 1986 Feb;174(2):73-83
3944597
Arch Neurol. 2008 Aug;65(8):1091-5
18695059
BMC Geriatr. 2010 Jun 09;10:36
20534132
Neurology. 1984 Jul;34(7):939-44
6610841
J Am Geriatr Soc. 1992 Sep;40(9):922-35
1512391
Brain. 1996 Feb;119 ( Pt 1):111-28
8624675